Necroptosis in development, inflammation and disease

Area of Science:

• Molecular Biology
• Cell Biology
• Immunology

Background:

• Receptor-interacting serine/threonine protein kinase 1 (RIPK1) is a known regulator of cell survival, inflammation, and disease.
• Early 2000s research identified RIPK1's role in a novel cell death pathway, termed necroptosis.
• Subsequent studies implicated RIPK3 and its substrate MLKL in necroptosis, establishing links to apoptosis.

Purpose of the Study:

• To outline the key discoveries in understanding necroptosis.
• To detail the roles of RIPK1, RIPK3, and MLKL in regulating cell death.
• To elucidate the interactions of these molecules in determining cell fate.

Main Methods:

• This is a Timeline article, synthesizing historical discoveries.
• It reviews published research on necroptosis regulators.
• It focuses on the identification and functional characterization of RIPK1, RIPK3, and MLKL.

Main Results:

• RIPK1 was identified as a key regulator of necroptosis.
• RIPK3 and MLKL were found to be essential components of the necroptotic pathway.
• Interactions between necroptosis and apoptosis pathways were established.

Conclusions:

• The discovery of RIPK1, RIPK3, and MLKL has significantly advanced the understanding of regulated cell death.
• These kinases and their substrates play critical roles in determining cell fate.
• Further research continues to uncover the complexities of necroptosis in health and disease.